Association between treatment resistance and cognitive function in schizophrenia
Introduction: Treatment-resistant schizophrenia (TRS) affects around 30% of individuals with schizophrenia. About half of the patients with TRS who are treated with clozapine do not show a meaningful clinical response, that is, clozapine resistance. To date, the relationship between cognitive functi...
Saved in:
| Main Authors: | Jiaqian Sun, Jie Yin Yee, Yuen Mei See, Charmaine Tang, Shushan Zheng, Boon Tat Ng, Jimmy Lee |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer – Medknow Publications
2024-10-01
|
| Series: | Singapore Medical Journal |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/singaporemedj.SMJ-2024-143 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Accelerated pace of frailty in patients with schizophrenia
by: Shun Yao, et al.
Published: (2025-01-01) -
Exploring the role of autistic traits in treatment-resistant and clozapine-resistant schizophrenia: a comparative study
by: Ahmet Selim Başaran, et al.
Published: (2025-04-01) -
Obesity, cytokines and psychopathology in patients with chronic schizophrenia
by: Menghan Lv, et al.
Published: (2025-07-01) -
Factors Associated with Poor Response to Clozapine in Patients with Treatment-resistant Schizophrenia
by: Jaison George, et al.
Published: (2025-07-01) -
Association between cognitive function, antioxidants, and clinical variables in Chinese patients with schizophrenia
by: Dan Li, et al.
Published: (2024-12-01)